3.07
price up icon0.00%   0.00
after-market Handel nachbörslich: 3.02 -0.05 -1.63%
loading
Schlusskurs vom Vortag:
$3.07
Offen:
$3.09
24-Stunden-Volumen:
527.63K
Relative Volume:
0.64
Marktkapitalisierung:
$424.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-45.44M
KGV:
-8.7714
EPS:
-0.35
Netto-Cashflow:
$-42.28M
1W Leistung:
+3.02%
1M Leistung:
+27.92%
6M Leistung:
+18.99%
1J Leistung:
+207.00%
1-Tages-Spanne:
Value
$2.96
$3.1296
1-Wochen-Bereich:
Value
$2.96
$3.27
52-Wochen-Spanne:
Value
$0.8741
$4.08

Compass Therapeutics Inc Stock (CMPX) Company Profile

Name
Firmenname
Compass Therapeutics Inc
Name
Telefon
617-500-8099
Name
Adresse
80 GUEST STREET, BOSTON
Name
Mitarbeiter
35
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CMPX's Discussions on Twitter

Vergleichen Sie CMPX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CMPX
Compass Therapeutics Inc
3.07 412.08M 0 -45.44M -42.28M -0.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-01 Fortgesetzt Raymond James Outperform
2025-04-02 Hochstufung Leerink Partners Market Perform → Outperform
2025-02-24 Eingeleitet Guggenheim Buy
2025-02-19 Eingeleitet Piper Sandler Overweight
2024-12-23 Eingeleitet D. Boral Capital Buy
2024-11-15 Herabstufung Leerink Partners Outperform → Market Perform
2024-09-16 Hochstufung Ladenburg Thalmann Neutral → Buy
2023-01-31 Eingeleitet Jefferies Buy
2023-01-27 Eingeleitet Stifel Buy
2022-05-23 Fortgesetzt H.C. Wainwright Buy
2022-03-15 Eingeleitet Ladenburg Thalmann Buy
2022-01-19 Eingeleitet B. Riley Securities Buy
2021-12-22 Eingeleitet Raymond James Outperform
2021-12-20 Eingeleitet SVB Leerink Outperform
2021-12-15 Eingeleitet Wedbush Outperform
Alle ansehen

Compass Therapeutics Inc Aktie (CMPX) Neueste Nachrichten

pulisher
Jul 22, 2025

What drives Compass Therapeutics Inc. stock priceFast-track wealth growth - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Compass Therapeutics (CMPX) Gains Analyst Confidence with Promising Cancer Pipeline - Insider Monkey

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Compass Therapeutics Inc. stockBreakthrough wealth creation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Compass Therapeutics Inc. a good long term investmentRemarkable growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Compass Therapeutics Inc. Stock Analysis and ForecastUnmatched profit potential - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

11 Best High Return Penny Stocks to Buy Now - Insider Monkey

Jul 21, 2025
pulisher
Jul 18, 2025

Is Compass Therapeutics Inc. stock a growth or value playHigh Return Setup Scanner - beatles.ru

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about Compass Therapeutics Inc. stock outlookFree Real-Time Market Predictions - beatles.ru

Jul 18, 2025
pulisher
Jul 16, 2025

What makes Compass Therapeutics Inc. stock price move sharply10x Return With Managed Risk - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why Compass Therapeutics Inc. stock attracts strong analyst attentionFree Access to Investment Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Axsome Therapeutics Inc. stock performs during market volatilityMulti Bagger Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Compass Therapeutics Inc. stock performs during market volatilityBreakout Level Watch - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Compass Therapeutics And 2 Other Promising Penny Stocks To Watch - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

Stifel reiterates Buy rating on Compass Therapeutics stock with $11 target - Investing.com Canada

Jul 15, 2025
pulisher
Jul 14, 2025

Contrasting Compass Therapeutics (NASDAQ:CMPX) & Generation Bio (NASDAQ:GBIO) - Defense World

Jul 14, 2025
pulisher
Jul 11, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Average Rating of “Buy” by Brokerages - Defense World

Jul 11, 2025
pulisher
Jul 10, 2025

Compass Therapeutics (CMPX) soars 4.01% on FDA Fast Track Designation - AInvest

Jul 10, 2025
pulisher
Jul 10, 2025

Vontobel Holding Ltd. Invests $57,000 in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jul 10, 2025
pulisher
Jul 04, 2025

Compass Therapeutics: Promising Clinical Trials and Strategic Confidence Earn Buy Rating - AInvest

Jul 04, 2025
pulisher
Jul 02, 2025

Compass Therapeutics (NASDAQ:CMPX) Upgraded at Raymond James Financial - Defense World

Jul 02, 2025
pulisher
Jul 01, 2025

H.C. Wainwright Remains a Buy on Compass Therapeutics (CMPX) - The Globe and Mail

Jul 01, 2025
pulisher
Jun 30, 2025

Compass Therapeutics, Inc.(NasdaqCM: CMPX) added to Russell 3000E Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 26, 2025

Compass Therapeutics Completes Phase 2 Study on CTX-009 for Metastatic Colorectal Cancer - TipRanks

Jun 26, 2025
pulisher
Jun 23, 2025

Dow Jumps Over 200 Points; FactSet Research Shares Gain After Q3 Results - Benzinga

Jun 23, 2025
pulisher
Jun 17, 2025

PD-1 and PD-L1 Inhibitors Competitor Landscape Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Compass Therapeutics, Aurigene Discovery Tech - The Globe and Mail

Jun 17, 2025
pulisher
Jun 16, 2025

SG Americas Securities LLC Buys 545,767 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Acquired by Bank of America Corp DE - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

Compass Therapeutics, Inc. (NASDAQ:CMPX) Shares Sold by Millennium Management LLC - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Two Sigma Investments LP Sells 48,021 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Compass Therapeutics Confirms Directors at Annual Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Cholangiocarcinoma Market Booming Worldwide, Estimated to Reach USD 2,334.4 Mn by 2032 | Incyte CorporationSOUTHEAST - SOUTHEAST - NEWS CHANNEL NEBRASKA

Jun 12, 2025
pulisher
Jun 12, 2025

Compass Therapeutics And 2 Other Promising Penny Stocks For Your Watchlist - Yahoo Finance

Jun 12, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Acquires New Holdings in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

CMPX to Participate in Virtual Meeting Hosted by Piper Sandler | - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

CMPX to Participate in Virtual Meeting Hosted by Piper Sandler | CMPX Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Two Sigma Advisers LP Cuts Stake in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Transition Metals (CVE:XTM) Shares Up 62.5% – Time to Buy? - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Atossa Therapeutics, Inc. (NASDAQ:ATOS) Shares Purchased by Two Sigma Advisers LP - Defense World

Jun 09, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Makes New $27,000 Investment in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

ProShare Advisors LLC Has $42,000 Position in Compass Therapeutics, Inc. (NASDAQ:CMPX) - Defense World

Jun 05, 2025

Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):